Firm Wire items are announcements made by the firms themselves. The desk confirms that the announcement was published and reproduces its factual content. It does not verify the claims in it, and publication is not an endorsement.
Wilson Sonsini says it advised Recursion on a $200 million follow-on offering
Wilson Sonsini said it advised Recursion Pharmaceuticals on an underwritten public offering that closed on October 16, 2026. The firm said the clinical-stage company uses AI in drug discovery and development and raised approximately $200 million before underwriting discounts, commissions and estimated expenses.
Key points
- Wilson Sonsini said the offering comprised 61,540,000 Class A common shares.Wilson Sonsini
- The firm reported a public offering price of $3.25 per share.Wilson Sonsini
- Wilson Sonsini named Patrick Schultheis and Jeana Kim among its advisers.Wilson Sonsini
- The firm also named Ashley Schmidt, Hanna Kim, Kathryn Obermiller and Naman Patel on its team.Wilson Sonsini